Published 2 Years AgoNovel PROTAC, SPNproNovel PROTAC, SPNproPublished 2 Years AgoComparison Between Phage Display Antibody Library and Hybridoma Comparison Between Phage Display Antibody Library and Hybridoma Published 2 Years AgomRNA technology, not only plays a part in the COVID-19 vaccine but also in cancemRNA technology, not only plays a part in the COVID-19 vaccine but also in cancer therapeuticsPublished 2 Years AgoSurprising: An ancient virus hidden in the human genome provides a new target foSurprising: An ancient virus hidden in the human genome provides a new target for esophageal cancer treatmentPublished 2 Years AgoAntibody screening technologies applied in innovative antibody discovery: PI Antibody screening technologies applied in innovative antibody discovery: PI Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoComparison Between Phage Display Antibody Library and Hybridoma Comparison Between Phage Display Antibody Library and Hybridoma Published 2 Years AgomRNA technology, not only plays a part in the COVID-19 vaccine but also in cancemRNA technology, not only plays a part in the COVID-19 vaccine but also in cancer therapeuticsPublished 2 Years AgoSurprising: An ancient virus hidden in the human genome provides a new target foSurprising: An ancient virus hidden in the human genome provides a new target for esophageal cancer treatmentPublished 2 Years AgoAntibody screening technologies applied in innovative antibody discovery: PI Antibody screening technologies applied in innovative antibody discovery: PI Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgomRNA technology, not only plays a part in the COVID-19 vaccine but also in cancemRNA technology, not only plays a part in the COVID-19 vaccine but also in cancer therapeuticsPublished 2 Years AgoSurprising: An ancient virus hidden in the human genome provides a new target foSurprising: An ancient virus hidden in the human genome provides a new target for esophageal cancer treatmentPublished 2 Years AgoAntibody screening technologies applied in innovative antibody discovery: PI Antibody screening technologies applied in innovative antibody discovery: PI Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoSurprising: An ancient virus hidden in the human genome provides a new target foSurprising: An ancient virus hidden in the human genome provides a new target for esophageal cancer treatmentPublished 2 Years AgoAntibody screening technologies applied in innovative antibody discovery: PI Antibody screening technologies applied in innovative antibody discovery: PI Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoAntibody screening technologies applied in innovative antibody discovery: PI Antibody screening technologies applied in innovative antibody discovery: PI Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoCan HER3 Become a Therapeutic Target? Can HER3 Become a Therapeutic Target? Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoADCs Against Lung Cancer: PI ADCs Against Lung Cancer: PI Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoThe Fight Against Zika: PII The Fight Against Zika: PII Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoThe Fight Against Zika: PI The Fight Against Zika: PI Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Published 2 Years AgoClinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Clinical Progress of Anti-SARS-CoV-2 Neutralizing Antibody (NAb)—PART III Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next
Previous | 1 - 2 - 3 - 4 - 5 - 6 | Next